Small molecules for regenerative medicine

About the speakers 

Frank Gleeson, CEO and co-founder of Satellos

During his international career, Mr Gleeson has been a key party to building more than 20 biomedical companies and has negotiated financing and M&A transactions of more than $500M. He has co-founded two companies with Dr Michael Rudnicki, including Satellos in 2018, and Verio Therapeutics which was acquired by Fate Therapeutics in 2010. Mr Gleeson has served on numerous Boards of private and public companies, and not-for profit organisations, including Chair of the Stem Cell Network.

Dr Michael Rudnicki, co-founder and Chief Discovery Officer at Satellos

An acknowledged world thought leader and scientific authority on muscle stem cell function and their role in muscle regeneration, in a landmark 2007 Cell paper, Dr Rudnicki was the first to define and characterise a subpopulation as bona fide multipotent stem cells in muscle tissue capable of both self renewal and regeneration, called muscle stem cells or satellite cells. Building on this seminal work, Dr Rudnicki has established a continuous record of foundational findings and discoveries spanning a 25-year research career. In so doing, he has transformed the field’s understanding of the nature and role muscle stem cells play in the lifelong repair and growth processes of skeletal muscle, the body’s largest organ.